Researchers have also suggested that zDHHC15 may be a new prognostic biomarker for patients with glioma and that targeting zDHHC15 could provide a promising strategy for the treatment of glioma (Liu et al., 2023). This evidence concerns the gene ZDHHC15 and central nervous system cancer.